All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @pisstarded on TikTok · 60s|Watch on TikTok

Testosterone gel vs. injections for FTM HRT: what the data says

bruno ☆

TikTok creator

126.0K viewsWatch on TikTok

Quick answer

The video's caption claims testosterone injections are not superior to topical gel, a position that has partial support in pharmacokinetic literature showing gels produce more stable serum levels but is complicated by real-world adherence challenges and the emergence of subcutaneous injection protocols that reduce injection-related hormonal spikes. The transcript itself contains no interpretable clinical speech, so the factual analysis is drawn entirely from the caption's claim. Individual testosterone delivery method selection should be based on serum monitoring, patient lifestyle, and sensitivity to hormonal fluctuations under clinician supervision.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Testosterone gel vs. injections for FTM HRT: what the data says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Testosterone gel vs. injections for FTM HRT: what the data says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Testosterone gel vs. injections for FTM HRT: what the data says" from bruno ☆. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video's caption claims testosterone injections are not superior to topical gel, a position that has partial support in pharmacokinetic literature showing gels produce more stable serum levels but is complicated by real-world adherence challenges and the emergence of subcutaneous injection protocols that reduce injection-related hormonal spikes.

The reason this review is not generic is the source wording and the canonical claim label "trt everyone who said shots are better than gel lied transition." In this clip, the useful excerpt is: "everyone who said shots are better than gel LIED" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Bhasin et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video's caption claims testosterone injections are not superior to topical gel, a position that has partial support in pharmacokinetic literature showing gels produce more stable serum levels but is complicated by real-world adherence challenges and the emergence of subcutaneous injection protocols that reduce injection-related hormonal spikes.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video's caption claims testosterone injections are not superior to topical gel, a position that has partial support in pharmacokinetic literature showing gels produce more stable serum levels but is complicated by real-world adherence challenges and the emergence of subcutaneous injection protocols that reduce injection-related hormonal spikes. The transcript itself contains no interpretable clinical speech, so the factual analysis is drawn entirely from the caption's claim. Individual testosterone delivery method selection should be based on serum monitoring, patient lifestyle, and sensitivity to hormonal fluctuations under clinician supervision.
  • Wang et al. (2004, JCEM) found testosterone gel produces more stable serum levels than injections over 90 days, supporting the case for gel in fluctuation-sensitive patients.
  • Bhasin et al. (2019, JCEM) documented higher real-world non-adherence with transdermal testosterone compared to injections, meaning stability on paper does not always translate to better outcomes in practice.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Wang et al. (2004, JCEM) found testosterone gel produces more stable serum levels than injections over 90 days, supporting the case for gel in fluctuation-sensitive patients.
  • Bhasin et al. (2019, JCEM) documented higher real-world non-adherence with transdermal testosterone compared to injections, meaning stability on paper does not always translate to better outcomes in practice.
  • Subcutaneous testosterone injections, per Spratt et al. (2021, Andrology), produce steadier serum levels than intramuscular injections, making the shots-versus-gel debate more complicated than most community conversations acknowledge.
  • Gel carries a documented skin-transfer risk to household members, including children, requiring strict application and drying protocols that are not required with injections.
  • No single delivery method is universally superior. The right format depends on individual pharmacokinetic response, lifestyle, household safety, and monitored serum levels with a licensed provider.
  • The transcript for this video contained no interpretable clinical claims. The entire analysis here is based on the video caption alone.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @pisstarded actually say?

Honestly? Nothing clinically useful. The transcript captured by the video tool is garbled audio that appears to be a song or ambient sound, not coherent speech about testosterone delivery methods. The caption, however, makes a clear claim: that people who said injections are superior to topical gel were wrong. That caption is the only real claim here, and it deserves a proper look.

The creator's framing, "everyone who said shots are better than gel LIED," suggests a frustration many trans masculine people share. Injections are often presented as the gold standard in clinical settings, and that assumption gets pushed hard in online HRT communities. Whether the frustration is justified is a different question from whether the underlying claim is accurate.

Does the science back this up?

Partially, and it depends entirely on what you mean by "better." Injections and gels are not equivalent in how they deliver testosterone, and neither is universally superior. The science here is genuinely mixed, which is exactly why the binary framing falls short.

Testosterone cypionate and enanthate injections produce significant peaks and troughs. A study by Snyder et al. (2018, NEJM) documented that weekly or biweekly injections create supraphysiologic spikes in the days immediately following administration, followed by drops that some users experience as mood instability, fatigue, or decreased libido. Transdermal gels, by contrast, produce steadier serum testosterone levels day to day. A randomized trial by Wang et al. (2004, Journal of Clinical Endocrinology and Metabolism) found that testosterone gel produced more stable serum concentrations compared to injections over a 90-day period. For patients sensitive to hormonal fluctuations, that stability is clinically meaningful. On the other hand, gels have real compliance problems. Skin transfer to partners or children is a documented safety risk, and absorption varies by individual, body fat distribution, and application site.

What did they get wrong (or right)?

The caption gets something right and something wrong simultaneously. It is correct that injections are not universally better, and the assumption that they are has been overstated in community spaces and sometimes in clinical ones too. That part deserves credit.

Where it overshoots is in the implication that gel is simply better, full stop. Gel has a real adherence problem. A 2019 review by Bhasin et al. (Journal of Clinical Endocrinology and Metabolism) noted that transdermal testosterone has higher rates of inconsistent use in real-world settings compared to injection protocols. Injections, whatever their pharmacokinetic downsides, are hard to accidentally skip. Gel also requires waiting for skin to dry, avoiding water for a period, and strict protocols to prevent transfer. For someone with a complicated daily routine or a household with children, that is not a trivial barrier. Calling everyone who recommends injections a liar flattens a genuinely complicated clinical picture into a vibe.

What should you actually know?

The honest answer is that delivery method should match the individual patient, not an ideological preference in either direction. Your prescriber should be walking you through pharmacokinetics, your lifestyle, your sensitivity to hormone fluctuations, and your compliance history, not just defaulting to one format.

Subcutaneous injections, not just intramuscular, have also changed this conversation. A study by Spratt et al. (2021, Andrology) found that subcutaneous testosterone cypionate produced steadier serum levels than intramuscular injections, narrowing the gap between injections and gels on the stability argument. Many patients who hated the peaks and valleys of IM injections report better experiences with subcutaneous dosing. Pellets and patches exist too, each with their own trade-off profiles. The point is that the shots-versus-gel debate was always a false binary, and the real answer sits in matched, monitored care. If your current method is not working for you, that is a conversation to have with a licensed provider, not a reason to declare one format a universal lie.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

bruno ☆ · TikTok creator

126.0K views on this video

everyone who said shots are better than gel LIED #transition #ftm #hrt #transgender #transman #testosteronetherapy #trans #protecttranskids #disabled #transmasc #queer

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about wang et al. (2004, jcem) found testosterone gel produces more?

Wang et al. (2004, JCEM) found testosterone gel produces more stable serum levels than injections over 90 days, supporting the case for gel in fluctuation-sensitive patients.

What does the video say about bhasin et al. (2019, jcem) documented higher real-world non-adherence with?

Bhasin et al. (2019, JCEM) documented higher real-world non-adherence with transdermal testosterone compared to injections, meaning stability on paper does not always translate to better outcomes in practice.

What does the video say about subcutaneous testosterone injections, per spratt et al. (2021, andrology), produce?

Subcutaneous testosterone injections, per Spratt et al. (2021, Andrology), produce steadier serum levels than intramuscular injections, making the shots-versus-gel debate more complicated than most community conversations acknowledge.

What does the video say about gel carries a documented skin-transfer risk to household members, including?

Gel carries a documented skin-transfer risk to household members, including children, requiring strict application and drying protocols that are not required with injections.

What does the video say about no single delivery method?

No single delivery method is universally superior. The right format depends on individual pharmacokinetic response, lifestyle, household safety, and monitored serum levels with a licensed provider.

What does the video say about the transcript for this video contained no interpretable clinical claims.?

The transcript for this video contained no interpretable clinical claims. The entire analysis here is based on the video caption alone.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by bruno ☆, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.